The global antimicrobial susceptibility test (AST) market is poised for a decade of rapid expansion, with its valuation projected to rise from USD 3.8 billion in 2025 to USD 8.3 billion by 2035. According to a comprehensive market analysis by Fact.MR, the industry is advancing at a compound annual growth rate (CAGR) of 8.1%, fueled by a global mandate to combat...